Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Shelton

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Leukemia|October 22, 2004
Inhibition of PI3K, mTOR and MEK signaling pathways promotes rapid apoptosis in B-lineage ALL in the presence of stromal cell supportF E Bertrand, J D Spengemen, J G Shelton, et al.
Molecular Immunology|September 22, 2001
Importance of the T cell receptor alpha-chain transmembrane distal region for assembly with cognate subunitsJ G Shelton, S Gülland, K Nicolson, et al.
Leukemia|October 8, 2004
Raf and VEGF: emerging therapeutic targets in Kaposi's sarcoma-associated herpesvirus infection and angiogenesis in hematopoietic and nonhematopoietic tumorsK E Hamden, A G Whitman, P W Ford, et al.
Leukemia|January 23, 2004
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesisL S Steelman, S C Pohnert, J G Shelton, et al.
Leukemia|September 13, 2003
Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferationJ G Shelton, P W Moye, L S Steelman, et al.
Leukemia|March 21, 2003
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapyF Chang, J T Lee, P M Navolanic, et al.
Leukemia|July 2, 2003
Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic interventionF Chang, L S Steelman, J T Lee, et al.
Leukemia|April 28, 2006
Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cellsF E Bertrand, L S Steelman, W H Chappell, et al.
Leukemia|May 23, 2001
Oncogene-dependent engraftment of human myeloid leukemia cells in immunosuppressed miceM Kiser, J A McCubrey, L S Steelman, et al.
Cancer Detection and Prevention|September 4, 2001
Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cellsJ A McCubrey, J T Lee, L S Steelman, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Leukemia|October 22, 2004
Inhibition of PI3K, mTOR and MEK signaling pathways promotes rapid apoptosis in B-lineage ALL in the presence of stromal cell supportF E Bertrand, J D Spengemen, J G Shelton, et al.
Molecular Immunology|September 22, 2001
Importance of the T cell receptor alpha-chain transmembrane distal region for assembly with cognate subunitsJ G Shelton, S Gülland, K Nicolson, et al.
Leukemia|October 8, 2004
Raf and VEGF: emerging therapeutic targets in Kaposi's sarcoma-associated herpesvirus infection and angiogenesis in hematopoietic and nonhematopoietic tumorsK E Hamden, A G Whitman, P W Ford, et al.
Leukemia|January 23, 2004
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesisL S Steelman, S C Pohnert, J G Shelton, et al.
Leukemia|September 13, 2003
Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferationJ G Shelton, P W Moye, L S Steelman, et al.
Leukemia|March 21, 2003
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapyF Chang, J T Lee, P M Navolanic, et al.
Leukemia|July 2, 2003
Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic interventionF Chang, L S Steelman, J T Lee, et al.
Leukemia|April 28, 2006
Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cellsF E Bertrand, L S Steelman, W H Chappell, et al.
Leukemia|May 23, 2001
Oncogene-dependent engraftment of human myeloid leukemia cells in immunosuppressed miceM Kiser, J A McCubrey, L S Steelman, et al.
Cancer Detection and Prevention|September 4, 2001
Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cellsJ A McCubrey, J T Lee, L S Steelman, et al.
Pageof 2